<p>Values are number (%), median (range) or mean (SD). JDM: juvenile dermatomyositis; NA: not applicable; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; SF-36 PCS: Short Form 36 physical component Summary; CHAQ: Childhood Health Assessment Questionnaire; DMARDs: disease modifying anti-rheumatic drugs; MDI: Myositis Damage Index; DAS: Disease Activity Score.</p><p>*p<0.05.</p>‡<p>n<i> = </i>46 pairs, only assessed in those >13 years;</p>†<p>n = 50 pairs.</p
Objective. To develop a composite DAS for JDM and provide preliminary evidence of its validity. Meth...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
The Pediatric Rheumatology International Trials Organisation (PRINTO) recently published criteria fo...
Background: It is currently impossible to predict the prognosis of patients with juvenile dermatomyo...
<p>Values for cytokine levels are mean (SD) pg/ml; n: all JDM = 54, controls = 54, JDM active = 28, ...
Objectives. To identify epidemiological, clinical and laboratory characteristics of juvenile dermato...
Background: Juvenile dermatomyositis (JDM) is the most common inflammatory myopathy in the pediatric...
The impact of duration of untreated symptoms in children with juvenile dermatomyositis (JDM) on clin...
Objective: This study determined if an accessible, serologic indicator of vascular disease activity,...
OBJECTIVES: To develop data-driven criteria for clinically inactive disease on and off therapy for j...
OBJECTIVE: Juvenile dermatomyositis (DM) is a systemic autoimmune disorder of unknown immunopathogen...
Background: Juvenile dermatomyositis is a rare childhood multisystem autoimmune disease involving pr...
Objective. To develop response criteria for juvenile dermatomyositis (DM). Methods. We analyzed the ...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
Objective. To develop a composite DAS for JDM and provide preliminary evidence of its validity. Meth...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
The Pediatric Rheumatology International Trials Organisation (PRINTO) recently published criteria fo...
Background: It is currently impossible to predict the prognosis of patients with juvenile dermatomyo...
<p>Values for cytokine levels are mean (SD) pg/ml; n: all JDM = 54, controls = 54, JDM active = 28, ...
Objectives. To identify epidemiological, clinical and laboratory characteristics of juvenile dermato...
Background: Juvenile dermatomyositis (JDM) is the most common inflammatory myopathy in the pediatric...
The impact of duration of untreated symptoms in children with juvenile dermatomyositis (JDM) on clin...
Objective: This study determined if an accessible, serologic indicator of vascular disease activity,...
OBJECTIVES: To develop data-driven criteria for clinically inactive disease on and off therapy for j...
OBJECTIVE: Juvenile dermatomyositis (DM) is a systemic autoimmune disorder of unknown immunopathogen...
Background: Juvenile dermatomyositis is a rare childhood multisystem autoimmune disease involving pr...
Objective. To develop response criteria for juvenile dermatomyositis (DM). Methods. We analyzed the ...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
Objective. To develop a composite DAS for JDM and provide preliminary evidence of its validity. Meth...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
The Pediatric Rheumatology International Trials Organisation (PRINTO) recently published criteria fo...